Company intelligence / Profile preview

Acentus

Ownership: Private
Development stage: Other

Overview

Acentus is a leading U.S. provider of disposable medical supplies delivered directly to patients’ homes. The company has grown rapidly by focusing on customer service and direct-to-home delivery for people with special healthcare needs. It specializes in products such as continuous glucose monitors for diabetes management and other vital homecare supplies. In November 2024, Henry Schein announced its intent to acquire Acentus.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Non-Academic Healthcare

Partnerships

Henry ScheinAlly Medical ServicesPreston Wound Care

Beyond the preview

Go deeper on Acentus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acentus.

Explore the full profile